TELA Bio, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2025: USD -38.36 M

TELA Bio, Inc. EBIT is USD -38.36 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 9.63% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • TELA Bio, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -34.99 M, a -14.82% change year over year.
  • TELA Bio, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -41.08 M, a 26.84% change year over year.
  • TELA Bio, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -32.38 M, a 23.90% change year over year.
  • TELA Bio, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -26.14 M, a 30.01% change year over year.
Key Data
Date EBIT EBITDA Net Income EPS (Diluted)